Vikalp K. Maheshwari
Hyderabad, TG, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors.
Journal: Journal of neuroendocrinology
Published: June 13, 2025
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial.
Journal: Leukemia
Published: November 23, 2022
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
Journal: Journal of cancer research and clinical oncology
Published: November 08, 2022
Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2- advanced breast cancer: a matching-adjusted indirect comparison.
Journal: Therapeutic advances in medical oncology
Published: October 28, 2022
Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP) in Italy.
Journal: PharmacoEconomics - open
Published: June 24, 2021
Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis.
Journal: PloS one
Published: June 19, 2019
Reduced Diabetes Mellitus-related Comorbidities by Regular Self-monitoring of Blood Glucose: Economic and Quality of Life Implications.
Journal: Indian journal of endocrinology and metabolism
Published: August 28, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026